Guggulsterone-mediated enhancement of radiosensitivity in human tumor cell lines

Frontiers in Oncology

Volumn 1, Issue JUL, 2011, Pages

  Choudhuri, Rajani ^a   DeGraff, William ^a   Gamson, Janet ^a   Mitchell, James B ^a   Cook, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell growth; DNA damage repair; Guggulsterone; NF B activation; Radiosensitization; Tumor cells

Indexed keywords

EID: 84873729222     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2011.00019     Document Type: Article

References (38)

1. Albright, N. (1987). Computer programs for the analysis of cellular survival data. Radiat. Res. 112, 331-340.
2. An, M. J., Cheon, J. H., Kim, S. W., Kim, E. S., Kim, T. I., and Kim, W. H. (2009). Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts. Cancer Lett. 279, 93-100.
3. Bovee, T. F., Schoonen, W. G., Hamers, A. R., Bento, M. J., and Peijnenburg, A. A. (2008). Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Anal. Bioanal. Chem. 390, 1111-1119.
4. Brobst, D. E., Ding, X., Creech, K. L., Goodwin, B., Kelley, B., and Staudinger, J. L. (2004). Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J. Pharmacol. Exp. Ther. 310, 528-535.
5. Burris, T. P., Montrose, C., Houck, K. A., Osborne, H. E., Bocchinfuso, W. P., Yaden, B. C., Cheng, C. C., Zink, R. W., Barr, R. J., Hepler, C. D., Krishnan, V., Bullock, H. A., Burris, L. L., Galvin, R. J., Bramlett, K., and Stayrook, K. R. (2005). The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand. Mol. Pharmacol. 67, 948-954.
6. Chander, R., Khanna, A. K., and Kaapor, N. K. (1996). Lipid lowering activity of guggulsterone from Commiphora mukul in hyperlipaemic rats. Phytother. Res. 10, 508-511.
7. Chanoux, R. A., Yin, B., Urtishak, K. A., Asare, A., Bassing, C. H., and Brown, E. J. (2009). ATR and H2AX cooperate in maintaining genome stability under replication stress. J. Biol. Chem. 284, 5994-6003.
8. Chautard, E., Loubeau, G., Tchirkov, A., Chassagne, J., Vermot-Desroches, C., Morel, L., and Verrelle, P. (2010). Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol. 12, 434-443.
9. Cosaceanu, D., Carapancea, M., Castro, J., Ekedahl, J., Kanter, L., Lewensohn, R., and Dricu, A. (2005). Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation. Cancer Lett. 222, 173-181.
10. Deorukhkar, A., and Krishnan, S. (2010). Targeting inflammatory pathways for tumor radiosensitization. Biochem. Pharmacol. 80, 1904-1914.
11. Dixit, V. P., Joshi, S., Sinha, R., Bharvava, S. K., and Varma, M. (1980). Hypolipidemic activity of guggal resin (Commiphora mukul) and garlic (Allium sativum Linn.) in dogs (Canis familiaris) and monkeys (Presbytis entellus entellus Dufresne). Biochem. Exp. Biol. 16, 421-424.
12. Hait, W. N., and Hambley, T. W. (2009). Targeted cancer therapeutics. Cancer Res. 69, 1263-1267; discussion 1267.
13. Hall, E. J., and Gaiaccia, A. J. (2006). Radiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins.
14. Hambley, T. W., and Hait, W. N. (2009). Is anticancer drug development heading in the right direction? Cancer Res. 69, 1259-1262.
15. Higgins, M. J., and Stearns, V. (2009). Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. Clin. Chem. 55, 1453-1455.
16. Li, N., and Karin, M. (1998). Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. U.S.A. 95, 13012-13017.
17. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. (1994). In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst. 86, 441-446.
18. Lv, N., Song, M. Y., Kim, E. K., Park, J. W., Kwon, K. B., and Park, B. H. (2008). Guggulsterone, a plant sterol, inhibits NF-kappaB activation and protects pancreatic beta cells from cytokine toxicity. Mol. Cell. Endocrinol. 289, 49-59.
19. Ma, W. W., and Adjei, A. A. (2009). Novel agents on the horizon for cancer therapy. CA Cancer J. Clin. 59, 111-137.
20. Macaulay, V. M., Salisbury, A. J., Bohula, E. A., Playford, M. P., Smorodinsky, N. I., and Shiloh, Y. (2001). Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase. Oncogene 20, 4029-4040.
21. Nitiss, J. L. (2009). DNA topoisomerase II and its growing repertoire of biological functions. Nat. Rev. Cancer 9, 327-337.
22. Nityanand, S., Srivastava, J. S., and Asthana, O. P. (1989). Clinical trials with gugulipid. A new hypolipidaemic agent. J. Assoc. Physicians India 37, 323-328.
23. Nohr, L. A., Rasmussen, L. B., and Straand, J. (2009). Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement. Ther. Med. 17, 16-22.
24. Paulsen, G. H., Strickert, T., Marthinsen, A. B., and Lundgren, S. (1996). Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol. 35, 1011-1019.
25. Peretz, S., Jensen, R., Baserga, R., and Glazer, P. M. (2001). ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 1676-1681.
26. Rocha, R. L., Hilsenbeck, S. G., Jackson, J. G., Vandenberg, C. L., Weng, C., Lee, A. V., and Yee, D. (1997). Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin. Cancer Res. 3, 103-109.
27. Samudio, I., Konopleva, M., Safe, S., Mcqueen, T., and Andreeff, M. (2005). Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure. Mol. Cancer Ther. 4, 1982-1992.
28. Shishodia, S., and Aggarwal, B. B. (2004). Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem. 279, 47148-47158.
29. Shishodia, S., Harikumar, K. B., Dass, S., Ramawat, K. G., and Aggarwal, B. B. (2008). The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res. 28, 3647-3664.
30. Shishodia, S., Sethi, G., Ahn, K. S., and Aggarwal, B. B. (2007). Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem. Pharmacol. 74, 118-130.
31. Singh, S. V., Choi, S., Zeng, Y., Hahm, E. R., and Xiao, D. (2007). Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res. 67, 7439-7449.
32. Singh, S. V., Zeng, Y., Xiao, D., Vogel, V. G., Nelson, J. B., Dhir, R., and Tripathi, Y. B. (2005). Caspase-dependent apoptosis induction by guggulsterone, a constituent of ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol. Cancer Ther. 4, 1747-1754.
33. Szapary, P. O., Wolfe, M. L., Bloedon, L. T., Cucchiara, A. J., Dermarderosian, A. H., Cirigliano, M. D., and Rader, D. J. (2003). Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA 290, 765-772.
34. Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., and Moore, D. D. (2002). A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296, 1703-1706.
35. Wang, C. Y., Mayo, M. W., and Baldwin, A. S. Jr. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787.
36. Wazer, D. E., Tercilla, O. F., Lin, P. S., and Schmidt-Ullrich, R. (1989). Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17B-estradiol and tamoxifen. Br. J. Radiol. 62, 1079-1083.
37. Xiao, D., and Singh, S. V. (2008). z-Guggulsterone, a constituent of ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo. Mol. Cancer Ther. 7, 171-180.
38. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Ambati, S., Hartzell, D. L., Park, H. J., and Baile, C. A. (2008). Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82, 1032-1039.